 |
市場調查報告書
商品編碼
1977803
2026-2034年全球外部二氧化碳去除系統市場規模、佔有率、趨勢和成長分析報告Global Extracorporeal CO2 Removal Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
預計外部二氧化碳去除系統的市場規模將從 2025 年的 1.0223 億美元成長到 2034 年的 2.0284 億美元，並預計從 2026 年到 2034 年將以 7.91% 的複合年成長率成長。
由於慢性阻塞性肺病肺病（COPD）和急性呼吸窘迫症候群等呼吸系統疾病的發生率不斷上升，全球體外二氧化碳清除設備市場正在擴張。這些設備能夠清除血液中的二氧化碳，從而幫助重度呼吸衰竭患者。加護病房（ICU）入院人數的增加以及對先進生命維持技術的需求，都顯著推動了市場成長。
膜式氧合系統和小型攜帶式設備的科技進步是主要驅動力。醫療機構擴大採用先進的呼吸支持系統來改善患者預後。臨床醫生意識提升以及吸煙相關肺部疾病盛行率的上升也促進了市場發展。對重症監護基礎設施的投資也發揮了重要作用。
展望未來，持續的臨床研發和產品創新將推動未來的成長。發展中地區醫療設施的擴建以及人們對非侵入性呼吸系統護理日益成長的興趣將創造新的機會。隨著全球呼吸系統疾病的持續增加，體外二氧化碳清除裝置的市場預計將穩定永續成長。
目錄
第1章：引言
第2章執行摘要
第3章 市場變數、趨勢與框架
- 市場譜系展望
- 滲透率和成長前景分析
- 價值鏈分析
- 法律規範
- 標準與合規性
- 監管影響分析
- 市場動態
- 市場促進因素
- 市場限制因素
- 市場機遇
- 市場挑戰
- 波特五力分析
- PESTLE分析
第4章 全球外部二氧化碳去除設備市場：依產品分類
- 市場分析、洞察與預測
- 外部二氧化碳去除裝置
- 一次性
- 其他
第5章 全球外部二氧化碳去除設備市場：依應用領域分類
- 市場分析、洞察與預測
- 急性呼吸窘迫症候群（ARDS）
- 慢性阻塞性肺病（COPD）
- 彌合肺移植差距
- 其他
第6章 全球外部二氧化碳去除設備市場：依接取方式分類
- 市場分析、洞察與預測
- 靜脈-靜脈
- 動脈和靜脈
第7章 全球外部二氧化碳去除設備市場：依最終用途分類
- 市場分析、洞察與預測
- 醫院
- 門診手術中心
- 診所
- 其他
第8章 全球外部二氧化碳去除設備市場：按地區分類
- 區域分析
- 北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
- 歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
- 拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
- 中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家
第9章 競爭情勢
- 最新趨勢
- 公司分類
- 供應鏈和銷售管道合作夥伴（根據現有資訊）
- 市場佔有率和市場定位分析（基於現有資訊）
- 供應商情況（基於現有資訊）
- 策略規劃
第10章：公司簡介
- 主要公司的市佔率分析
- 公司簡介
- Medtronic
- Getinge AB
- Xenios AG
- ALung Technologies Inc
- Estor SPA
- Medica SPA
- Aferetica Srl
- Baxter
- X-COR Therapeutics
- Hemovent GmbH
- Abiomed Inc
The Extracorporeal CO2 Removal Devices Market size is expected to reach USD 202.84 Million in 2034 from USD 102.23 Million (2025) growing at a CAGR of 7.91% during 2026-2034.
The global extracorporeal CO2 removal devices market is expanding due to the rising incidence of respiratory disorders such as COPD and acute respiratory distress syndrome. These devices assist in removing carbon dioxide from the blood, supporting patients with severe respiratory failure. Increasing ICU admissions and demand for advanced life-support technologies are contributing significantly to market growth.
Technological advancements in membrane oxygenation systems and compact portable devices are key drivers. Healthcare facilities are increasingly adopting advanced respiratory support systems to improve patient outcomes. Growing awareness among clinicians and rising prevalence of smoking-related lung diseases further support market expansion. Investments in critical care infrastructure are also playing an important role.
Looking ahead, ongoing clinical research and product innovation will drive future growth. Expanding healthcare facilities in developing regions and increasing focus on non-invasive respiratory management will create new opportunities. As respiratory disorders continue to rise globally, the extracorporeal CO2 removal devices market is expected to witness steady and sustainable growth.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Extracorporeal CO2 Machines
- Disposables
- Others
By Application
- Acute respiratory distress syndrome (ARDS)
- Chronic obstructive pulmonary disease (COPD)
- Bridge to lung transplant
- Others
By Access
- Venovenous
- Arteriovenous
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
COMPANIES PROFILED
- Medtronic, Getinge AB, Xenios AG, ALung Technologies Inc, Estor SPA, Medica SPA, Aferetica Srl, Baxter, XCOR Therapeutics, Hemovent GmbH, Abiomed Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Extracorporeal CO2 Machines Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Disposables Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Acute respiratory distress syndrome (ARDS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Chronic obstructive pulmonary disease (COPD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Bridge to lung transplant Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY ACCESS 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Access
- 6.2. Venovenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Arteriovenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY END-USE 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End-use
- 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Application
- 8.2.3 By Access
- 8.2.4 By End-use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Application
- 8.3.3 By Access
- 8.3.4 By End-use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Application
- 8.4.3 By Access
- 8.4.4 By End-use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Application
- 8.5.3 By Access
- 8.5.4 By End-use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Application
- 8.6.3 By Access
- 8.6.4 By End-use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Medtronic
- 10.2.2 Getinge AB
- 10.2.3 Xenios AG
- 10.2.4 ALung Technologies Inc
- 10.2.5 Estor S.P.A
- 10.2.6 Medica S.P.A
- 10.2.7 Aferetica Srl
- 10.2.8 Baxter
- 10.2.9 X-COR Therapeutics
- 10.2.10 Hemovent GmbH
- 10.2.11 Abiomed Inc
